ORRF Stock Analysis: Orrstown Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 864m USD | 12M Return: 28.3% | US6873801053 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.30M
EPS Trend: 97.4%
Qual. Beats: 0
Rev. Trend: 90.7%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Orrstown Financial Services, Inc. (ORRF) is the bank holding company for Orrstown Bank, a community-oriented commercial bank founded in 1919 and headquartered in Harrisburg, Pennsylvania. The company provides traditional deposit and lending products to retail, commercial, non-profit, and government clients across its market footprint.
Its deposit base consists of checking, savings, time, demand, money market, and certificates of deposit accounts. On the lending side, Orrstown originates a diversified mix of commercial loans (including commercial real estate, equipment, construction, working capital, and industrial loans), consumer loans such as home equity loans and lines of credit, residential mortgages, agricultural loans, acquisition and development loans, municipal loans, and installment loans.
Beyond core banking, the company operates a wealth management segment under the Orrstown Financial Advisors name, offering fiduciary, investment advisory, and trust services, and also provides retail brokerage through a third-party broker/dealer arrangement along with insurance products. As a regional bank under the bank holding company structure, ORRF combines traditional spread-based community banking with fee-generating advisory services to diversify its revenue mix.
- Net interest margin expansion drives earnings growth
- Commercial real estate loan losses threaten credit quality
- Deposit costs rise faster than loan yields compress margins
| Net Income: 87.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.09 > 1.0 |
| NWC/Revenue: -1.09k% < 20% (prev -1.04k%; Δ -46.20% < -1%) |
| CFO/TA 0.01 > 3% & CFO 61.7m > Net Income 87.3m |
| Net Debt (-619.7m) to EBITDA (122.1m): -5.08 < 3 |
| Current Ratio: 0.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (19.5m) vs 12m ago 0.72% < -2% |
| Gross Margin: 71.38% > 18% (prev 69.08%; Δ 2.30% > 0.5%) |
| Asset Turnover: 6.45% > 50% (prev 6.47%; Δ -0.02% > 0%) |
| Interest Coverage Ratio: 1.07 > 6 (EBIT TTM 108.1m / Interest Expense TTM 101.4m) |
| A: -0.69 (Total Current Assets 1.07b - Total Current Liabilities 5.00b) / Total Assets 5.71b |
| B: 0.04 (Retained Earnings 234.9m / Total Assets 5.71b) |
| C: 0.02 (EBIT TTM 108.1m / Avg Total Assets 5.59b) |
| D: 0.12 (Book Value of Equity 605.2m / Total Liabilities 5.10b) |
| Altman-Z'' = -4.13 = D |
| DSRI: 1.00 (Receivables 20.7m/20.4m, Revenue 360.2m/353.7m) |
| GMI: 0.97 (GM 69.08% / 71.38%) |
| AQI: 0.97 (AQ_t 0.80 / AQ_t-1 0.83) |
| SGI: 1.02 (Revenue 360.2m / 353.7m) |
| TATA: 0.00 (NI 87.3m - CFO 61.7m) / TA 5.71b) |
| Beneish M = -3.06 (Cap -4..+1) = AA |
As of November 20, 2026, the stock is trading at USD 41.82 with a total of 75,137 shares traded. Over the past week, the price has changed by -5.17%, over one month by +1.91%, over three months by +0.81% and over the past year by +28.30%.
Current recommended Stop Loss: 40.60 (which is 2.9% or 1.1 ATR below the current price).
Orrstown Financial has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ORRF.
- StrongBuy: 2
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 47.5 | 13.6% |
P/E Trailing = 9.7862
P/E Forward = 8.8889
P/S = 3.3623
P/B = 1.4353
Revenue TTM = 360.2m USD
EBIT TTM = 108.1m USD
EBITDA TTM = 122.1m USD
Long Term Debt = 425.4m USD (from longTermDebt, last quarter)
Short Term Debt = 417.3m USD (from shortTermDebt, last quarter)
Debt = 425.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -619.7m USD (calculated: Debt 425.4m - CCE 1.05b)
Enterprise Value = 244.6m USD (864.3m + Debt 425.4m - CCE 1.05b)
Interest Coverage Ratio = 1.07 (Ebit TTM 108.1m / Interest Expense TTM 101.4m)
EV/FCF = 4.11x (Enterprise Value 244.6m / FCF TTM 59.5m)
FCF Yield = 24.31% (FCF TTM 59.5m / Enterprise Value 244.6m)
FCF Margin = 16.50% (FCF TTM 59.5m / Revenue TTM 360.2m)
Net Margin = 24.23% (Net Income TTM 87.3m / Revenue TTM 360.2m)
Gross Margin = 71.38% ((Revenue TTM 360.2m - Cost of Revenue TTM 103.1m) / Revenue TTM)
Gross Margin QoQ = 72.06% (prev 70.40%)
Tobins Q-Ratio = 0.04 (Enterprise Value 244.6m / Total Assets 5.71b)
Interest Expense / Debt = 23.83% (Interest Expense 101.4m / Debt 425.4m)
Taxrate = 19.18% (20.7m / 108.0m)
NOPAT = 87.3m (EBIT 108.1m * (1 - 19.18%))
Current Ratio = 0.21 (Total Current Assets 1.07b / Total Current Liabilities 5.00b)
Debt / Equity = 0.70 (Debt 425.4m / totalStockholderEquity, last quarter 605.2m)
Debt / EBITDA = -5.08 (Net Debt -619.7m / EBITDA 122.1m)
Debt / FCF = -10.42 (Net Debt -619.7m / FCF TTM 59.5m)
Total Stockholder Equity = 605.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.56% (Net Income 87.3m / Total Assets 5.71b)
RoE = 14.42% (Net Income TTM 87.3m / Total Stockholder Equity 605.4m)
RoCE = 10.48% (EBIT 108.1m / Capital Employed (Equity 605.4m + L.T.Debt 425.4m))
RoIC = 7.89% (NOPAT 87.3m / Invested Capital 1.11b)
WACC = 11.25% (E(864.3m)/V(1.29b) * Re(7.31%) + D(425.4m)/V(1.29b) * Rd(23.83%) * (1-Tc(0.19)))
Discount Rate = 7.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 48.76 | Cagr: 31.39%
[DCF] Terminal Value 65.30% ; FCFF base≈60.4m ; Y1≈58.7m ; Y5≈58.2m
[DCF] Fair Price = 62.63 (EV 612.2m - Net Debt -619.7m = Equity 1.23b / Shares 19.7m; r=11.25% [WACC]; 5y FCF grow -3.91% → 2.50% )
EPS Correlation: 97.43 | EPS CAGR: 11.41% | SUE: 0.71 | # QB: 0
Revenue Correlation: 90.73 | Revenue CAGR: 34.49% | SUE: 0.81 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.12 | Chg30d=+5.65% | Revisions=+57% | Analysts=5
EPS current Year (2026-12-31): EPS=4.34 | Chg30d=+0.52% | Revisions=+57% | GrowthEPS=+1.4% | GrowthRev=+2.7%
EPS next Year (2027-12-31): EPS=4.64 | Chg30d=+5.36% | Revisions=+57% | GrowthEPS=+6.8% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: +80% (up=12, down=0)